source
- After Apellis deal, Biogen looks to fill early-stage pipelineBiogen is still looking at deals even after earmarking $5.6 billion to buy Apellis Pharmaceuticals earlier this month. “Most of what we're going to be focusing on is early-stage development and res…Endpoints · 3mo ago↗ source
- AstraZeneca rekindles UK relationship, pledges £300M to expandAstraZeneca and the UK government are back in each other's good graces. AstraZeneca on Wednesday said it is lifting its UK investment pause, with a £300 million budget to finish construction of a n…Endpoints · 3mo ago↗ source
- STAT+: A patent win for Pfizer and BridgeBioA change to FDA clinical trial data review, Rocket sells its priority review voucher, and more biotech news from The ReadoutSTAT · 3mo ago